Cargando…

Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial

INTRODUCTION: Painful surgical procedures require adequate sedation and analgesia. A vast array of medications can be used for Procedural Sedation and Analgesia (PSA) in Emergency Departments (EDs). OBJECTIVE: The present study was conducted to compare Propofol-Ketamine (PK) and Propofol-Fentanyl (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Mofidi, Mani, Rouhi, Roghayeh, Mahshidfar, Babak, Abbasi, Saeed, Hafezimoghadam, Peyman, Rezai, Mahdi, Farsi, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548145/
https://www.ncbi.nlm.nih.gov/pubmed/31172107
http://dx.doi.org/10.22114/AJEM.v0i0.102
_version_ 1783423809567588352
author Mofidi, Mani
Rouhi, Roghayeh
Mahshidfar, Babak
Abbasi, Saeed
Hafezimoghadam, Peyman
Rezai, Mahdi
Farsi, Davood
author_facet Mofidi, Mani
Rouhi, Roghayeh
Mahshidfar, Babak
Abbasi, Saeed
Hafezimoghadam, Peyman
Rezai, Mahdi
Farsi, Davood
author_sort Mofidi, Mani
collection PubMed
description INTRODUCTION: Painful surgical procedures require adequate sedation and analgesia. A vast array of medications can be used for Procedural Sedation and Analgesia (PSA) in Emergency Departments (EDs). OBJECTIVE: The present study was conducted to compare Propofol-Ketamine (PK) and Propofol-Fentanyl (PF) compounds in patients undergoing closed reduction in EDs. METHODS: This randomized, double-blind, clinical trial was conducted on 110 consecutive patients who required sedation for closed reduction. The patients were randomly divided into two groups of equal sizes. The PK group received an intravenous bolus of 1 mg/kg of propofol plus 0.5 mg/kg of ketamine, and the PF group received an intravenous bolus of 1 mg/kg of propofol plus 1 µg/kg of fentanyl. The analgesic effect and success rate were the primary outcomes under study. RESULTS: The PK group achieved more effective analgesia at the end of the experiment. The success rate was almost the same in both groups Shivering (p=0.005) and a drop in oxygen saturation to below 92% (p=0.048) were two side effects that were more prevalent in the FK group. The mean recovery time was significantly shorter in the PK group (p<0.001). The patients in the PK group were more satisfied. CONCLUSION: In comparison with the PF compound, the use of KP leads to better pain relief and greater patient satisfaction and shorter sedation time in PSA.
format Online
Article
Text
id pubmed-6548145
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-65481452019-06-06 Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial Mofidi, Mani Rouhi, Roghayeh Mahshidfar, Babak Abbasi, Saeed Hafezimoghadam, Peyman Rezai, Mahdi Farsi, Davood Adv J Emerg Med Original Article INTRODUCTION: Painful surgical procedures require adequate sedation and analgesia. A vast array of medications can be used for Procedural Sedation and Analgesia (PSA) in Emergency Departments (EDs). OBJECTIVE: The present study was conducted to compare Propofol-Ketamine (PK) and Propofol-Fentanyl (PF) compounds in patients undergoing closed reduction in EDs. METHODS: This randomized, double-blind, clinical trial was conducted on 110 consecutive patients who required sedation for closed reduction. The patients were randomly divided into two groups of equal sizes. The PK group received an intravenous bolus of 1 mg/kg of propofol plus 0.5 mg/kg of ketamine, and the PF group received an intravenous bolus of 1 mg/kg of propofol plus 1 µg/kg of fentanyl. The analgesic effect and success rate were the primary outcomes under study. RESULTS: The PK group achieved more effective analgesia at the end of the experiment. The success rate was almost the same in both groups Shivering (p=0.005) and a drop in oxygen saturation to below 92% (p=0.048) were two side effects that were more prevalent in the FK group. The mean recovery time was significantly shorter in the PK group (p<0.001). The patients in the PK group were more satisfied. CONCLUSION: In comparison with the PF compound, the use of KP leads to better pain relief and greater patient satisfaction and shorter sedation time in PSA. Tehran University of Medical Sciences 2018-09-04 /pmc/articles/PMC6548145/ /pubmed/31172107 http://dx.doi.org/10.22114/AJEM.v0i0.102 Text en © 2018 Tehran University of Medical Sciences This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Mofidi, Mani
Rouhi, Roghayeh
Mahshidfar, Babak
Abbasi, Saeed
Hafezimoghadam, Peyman
Rezai, Mahdi
Farsi, Davood
Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial
title Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial
title_full Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial
title_fullStr Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial
title_full_unstemmed Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial
title_short Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial
title_sort propofol-ketamine vs. propofol-fentanyl combinations in patients undergoing closed reduction: a randomized, double-blind, clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548145/
https://www.ncbi.nlm.nih.gov/pubmed/31172107
http://dx.doi.org/10.22114/AJEM.v0i0.102
work_keys_str_mv AT mofidimani propofolketaminevspropofolfentanylcombinationsinpatientsundergoingclosedreductionarandomizeddoubleblindclinicaltrial
AT rouhiroghayeh propofolketaminevspropofolfentanylcombinationsinpatientsundergoingclosedreductionarandomizeddoubleblindclinicaltrial
AT mahshidfarbabak propofolketaminevspropofolfentanylcombinationsinpatientsundergoingclosedreductionarandomizeddoubleblindclinicaltrial
AT abbasisaeed propofolketaminevspropofolfentanylcombinationsinpatientsundergoingclosedreductionarandomizeddoubleblindclinicaltrial
AT hafezimoghadampeyman propofolketaminevspropofolfentanylcombinationsinpatientsundergoingclosedreductionarandomizeddoubleblindclinicaltrial
AT rezaimahdi propofolketaminevspropofolfentanylcombinationsinpatientsundergoingclosedreductionarandomizeddoubleblindclinicaltrial
AT farsidavood propofolketaminevspropofolfentanylcombinationsinpatientsundergoingclosedreductionarandomizeddoubleblindclinicaltrial